Xylem (XYL) Operating Expenses (2010 - 2026)

Xylem's Operating Expenses history runs 17 years deep, the most recent figure standing at $559.0 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 4.1% year-over-year to $559.0 million in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 3.5% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 2.22% from the prior year.
• Operating Expenses fell to $559.0 million in Q1 2026 per XYL's latest filing, from $579.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $590.0 million in Q4 2024 and bottomed at $356.0 million in Q1 2022.
• The 5-year median for Operating Expenses is $543.0 million (2024), against an average of $502.4 million.
• Across the five-year window, Operating Expenses soared 60.96% in 2023 and retreated 12.04% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $376.0 million in 2022, then jumped by 44.95% to $545.0 million in 2023, then rose by 8.26% to $590.0 million in 2024, then fell by 1.86% to $579.0 million in 2025, then retreated by 3.45% to $559.0 million in 2026.
• Per Business Quant, the three latest XYL Operating Expenses figures stand at $559.0 million (Q1 2026), $579.0 million (Q4 2025), and $549.0 million (Q3 2025).